Magnetic Stimulation as an add on treatment for Depression.

Effectiveness of Repetitive Transcranial Magnetic Stimulation (rTMS) as an adjuvant for Severe Depression - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/09/094384

Enrollment

Registered

2025-09-08

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F322- Major depressive disorder, singleepisode, severe without psychotic features

Interventions

Intervention1: Repetitive Transcranial Magnetic Stimulation: A total of 15 sessions (on a daily basis) of rTMS will be delivered over a period of three weeks following the uniform treatment protocol a

Eligibility

Inclusion criteria

Inclusion criteria: 1.Right Handed patients 2.Of Ages 18-60 Years, Of Both Sexes, 3.Who Are Diagnosed With Severe Depression According To ICD 11.

Exclusion criteria

Exclusion criteria: 1. Medical commodities that need immediate attention 2. Any contraindication to rTMS such as any metallic implants in close contact to coil, cochlear implants 3. Any other psychiatric co morbidity

Design outcomes

Primary

Measure	Time frame
To assess the effectiveness of Repetitive Transcranial Magnetic Stimulation (rTMS) as an adjuvant in Severe Depression.Timepoint: After 10 rTMS sessions	—

Secondary

Measure	Time frame
To assess the number of rTMS sessions required to bring about a response (less than 50% scores) in the identified patients in HDRS.Timepoint: After every 2 rTMS sessions;To assess the improvement of functional capacity of the patients using GAF scale with rTMS.Timepoint: Before and after 10 rTMS sessions	—

Countries

India

Contacts

Public ContactAmrutha Gudimetla

NRI Academy of Sciences

dr.tvpavi@gmail.com9849220263

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026